William D. Atchison
Ph.D., 1980, University of Wisconsin
Professor, Dept. of Pharmacology & Toxicology
-Neurotransmitter release and synaptic transmission; models of human neuromuscular disorders of peripheral and central neurotransmission, chemical neurotoxicity, ion channel pharmacology.

S. Marc Breedlove
Ph.D. 1982, UCLA
Barnett Rosenberg Professor of Neuroscience, Dept. of Psychology and Dept. of Zoology.
- Sexual differentiation of the brain and spinal cord; effects of hormones and experience on plasticity in the developing and mature nervous system.

Peter J. R. Cobbett
Ph.D., 1981, St. Andrews University - Scotland
Associate Professor, Dept. of Pharmacology & Toxicology
- Electrophysiology of neuroendocrine cells, secretion of vasopressin and oxytocin, neuroglial plasticity; Neuromuscular physiology of human and veterinary parasites.

Timothy J. Collier
Ph.D., 1983, Northwestern University
Professor, TSMM/CHM
- Models of Parkinson’s disease to study mechanisms of degeneration and therapeutics; neurobiology of aging.

Ke Dong
PhD., 1993, Cornell University
Associate Professor, Dept. of Entomology
- Insect voltage-gated ion channels, interaction between ion channels and insecticides and other neurotoxins, and molecular mechanisms of insecticide resistance.

James J. Galligan
Ph.D., 1983, University of Arizona
Professor, Dept. of Pharmacology & Toxicology
- Neurophysiology and pharmacology of autonomic nerves.

Kathleen Gallo
Ph.D., 1992, Harvard University
Professor, Departments of Physiology, Biochemistry, and Molecular Biology
- Protein kinase signaling in neurogenerative diseases.

John L. Goudreau
Ph.D., 1994; D.O., 1995, Michigan State University
Assistant Professor, Dept. of Neurology & Ophthalmology
- Genetic and environmental factors in the pathogenesis of Parkinson's Disease.

Colleen C. Hegg
Ph.D., 1996, University of Wisconsin - Madison
Assistant Professor, Dept. of Pharmacology & Toxicology
- Elucidating the mechanisms of neuroregeneration.

Steven R. Heidemann
Ph.D., 1976, Princeton University
Professor, Dept. of Physiology
- Cytomechanics of neural development.

Cynthia L. Jordan
Ph.D. 1988, UCLA
Associate Professor, Dept. of Neuroscience & Psychology
- Steroid regulation of cellular development; cellular and molecular mechanisms of steroid action on behavior; neuronal plasticity and development.

Nicholas M. Kanaan
Ph.D., 2007, Rush University Medical Center
Assistant Professor, Division of Translational Science and Molecular Medicine
- Aging and neurodegenerative diseases (e.g., Alzheimer’s and Parkinson’s disease) and animal models of disease.

Barbara Kaplan
Ph.D., 2001, Michigan State University
Assistant Professor, Center for Integrative Toxicology (CVM)
- Neuroimmune Interactions and Drugs of Abuse

András M. Komáromy*
Ph.D., 2002, Comparative Ophthalmology
Dr., 1993, University of Zurich, Veterinary Medicine
-Molecular and cellular mechanisms of inherited retinal and optic nerve diseases; gene therapy

Weiming Li
Ph.D., 1994 University of Minnesota - Twin Cities
Associate Professor, Dept. of Fisheries and Wildlife, CNAR.
- Pheromone regulation of behavior and neuroendocrine olfaction, functional genomics.

Jack W. Lipton*
Ph.D., 1993 University of California, Los Angeles
Professor, Dept of Neurology & Opthalmology
Director, Div. of Translational Science & Molecular Medicine, College of Human Medicine
- Developmental exposure to drugs of abuse, development of the dopamine system, etiology and experimental therapeutics of Parkinson’s disease

Joseph S. Lonstein
Ph.D., 1997, Rutgers University
Assistant Professor, Dept. of Psychology
- Neural, sensory, and hormonal control of parental and emotional behaviors during lactation.

Keith J. Lookingland
Ph.D., 1982, University of Maryland
Associate Professor, Dept. of Pharmacology & Toxicology
- Development of neuroprotective pharmacological agents and strategies for the treatment of dopamine neurodegenerative disorders including Parkinson's Disease and Restless Legs Syndrome (RLS).

Kathryn L. Lovell
Ph.D., 1975, Michigan State University
Professor, Dept. of Neurology and Ophthalmology
Director, Block I, College of Human Medicine
- Pathogenesis of nervous system abnormalities in inherited metabolic diseases.

Fredric P. Manfredsson
Ph.D., 2006, University of Florida
Assistant Professor, Division of Translational Science and Molecular Medicine
- Development of virally-mediated CNS gene-therapy in the study, and treatment, of neurodegenerative disease.

Kyle Miller
Ph.D., 1996, Emory University
Assistant Professor, Dept. of Zoology
- Axonal elongation and organelle transport in neurons.

Puliyur MohanKumar
B.V. Sc., Ph.D., 1993, Kansas State University
Associate Professor, Dept. of Pathobiology and Diagnostic Investigation
- Age-related changes in the activity of brain monoamines in hormone regulating nuclei of the hypothalamus.

Sheba MohanKumar
B.V. Sc., 1988, Madras Veterinary College, M.S.
Ph.D., 1996, Kansas State University
Assistant Professor, Dept. of Pharmacology & Toxicology
- Neuroimmune-endocrine interactions.

Joseph L. Nuñez
Ph.D., 2000, University of Illinois at Urbana-Champaign
Assistant Professor, Dept. of Psychology and Neuroscience
- Effect of steroid hormones and GABAergic systems in a model of early brain injury, behavioral outcomes and neuroprotection.

Mary B. Rheuben
Ph.D., 1971, University of California-San Diego
Professor, Dept. of Pathobiology and Diagnostic Investigation
- Synaptic vesicle recycling and endocytosis in Drosophila neuromuscular junctions.

Sharleen T. Sakai
Ph.D., 1980, Michigan State University
Professor, Department of Psychology
- Anatomical substrates of motor control systems.

Stephen P. Schneider
Ph.D., 1982, Emory University
Associate Professor, Dept. of Physiology
- Mechanisms of sensory processing in spinal cord.

Cheryl L. Sisk
Ph.D., 1980, Florida State University
Director, Neuroscience Program
Professor, Dept. of Psychology
- Neuroendocrinology, neural development during puberty and adolescence, steroid hormone regulation of neural development and behavior.

Caryl E. Sortwell
Ph.D., 1994, University of Illinois at Chicago
Professor, Dept of Neurology
- Experimental treatment strategies in Parkison's disease.

Kathy Steece-Collier
Ph.D., 1986, University of Illinois at Chicago
Professor, Division of Translation Science and Molecular Medicine
- Brain plasticity in neurodegenerative disease models.

Kenneth I. Strauss
Ph.D., 1990, Hahnemann University
Associate Professor, Translational Science and Molecular Medicine
- Regulation of arachidonic acid metabolism in the brain modulates inflammation and recovery after brain injuries.

Greg Swain
Ph.D., 1991, University of Kansas
Professor, Dept. Chemistry
- Neural control mechanisms of arteries and veins in hypertension, and maturation of the enteric nervous system and its regulatory function in the gastrointestinal tract.

Petra Telgkamp
Ph.D., 2000, University of Chicago
Assistant Professor, Dept. of Zoology
- Neuronal networks underlying behavior; cellular mechanisms, plasticity and neuromodulation.

Juli S. Wade
Ph.D., 1992, University of Texas-Austin
Professor, Dept. of Psychology & Zoology
- Neuroendocrine regulation of sex differences in brain and behavior.

Donna H. Wang
M.D., 1984, Sun Yan-sen University of Medical Sciences
Professor, Dept. of Medicine and Dept. of Pharmacology & Toxicology
- Cellular and molecular mechanisms underlying salt sensitive hypertension.

Hongbing Wang
Ph.D., 1998, UCLA
Assistant Professor, Dept. of Physiology and Neuroscience
- Cyclic AMP signaling and neuroplasticity.

Arthur J. Weber
Ph.D., 1984, University of Wisconsin
Associate Professor, Dept. of Physiology
- Structure-function relation of retinal ganglion cells undergoing glaucoma-related degeneration in the primate eye. Development of treatment strategies aimed at mitigating or preventing glaucomatous retinal ganglion cell degeneration.

Lily Yan
M.D., Ph.D., 2000, Kobe University School of Medicine, Japan
Assistant Professor, Dept. of Psychology
- molecular, cellular and neural mechanisms underlying circadian rhythm regulation.

(Go to Top of Page)